| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a19efb85153bd83f1c87e82dc0e9b9da |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate |
2021-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba9633e3c63f3512d4397678c68f3a73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd8bcc61d3d4dcd6b23a821dd1fd0de5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c65552c4d6928bc3d88f67165cfcc30 |
| publicationDate |
2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112972468-A |
| titleOfInvention |
Use of alkaloid compound Hip in the preparation of products for preventing and/or treating heart damage |
| abstract |
The invention discloses the use of the alkaloid compound Hip in the preparation of products for preventing and/or treating cardiac injury. The activity research of the alkaloid compound Hip has been carried out to verify that the alkaloid compound Hip provided by the invention can inhibit the myocardial toxicity induced by the effect of Apoptosis, by down-regulating the expression levels of p-JNK and/or Cleaved-Caspase-3 to inhibit the apoptosis of cardiomyocytes induced by anthracycline DOX, thereby relieving cardiotoxicity and preventing and/or treating cardiotoxicity The effect can be used to prepare a drug for preventing and/or treating myocardial injury-related diseases. |
| priorityDate |
2021-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |